{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T18:36:04Z","timestamp":1777660564615,"version":"3.51.4"},"reference-count":39,"publisher":"SAGE Publications","issue":"3-4","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Human Antibodies"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Herpes simplex viruses belong to the herpesvirus family, which are double-stranded DNA viruses. Type 1 is transmitted through non-sexual contact through childhood, while type 2 is usually transmitted through sexual contact during adulthood. Cytomegalovirus shares many characteristics with other herpes viruses, it is a prevalent opportunistic infection in human immunodeficiency virus (HIV) infected patients and is a major cause of viral complications among organ donation recipients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>The purpose of this study was to investigate the frequency of immunoglobulin antibodies for HSV-1, HSV-2, and CMV viruses among latency and reactivation cases using ELISA technique.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methodology<\/jats:title>\n                    <jats:p>\n                      A cross-sectional investigation was performed among 147 (58 males, 89 females) aged 18\u201360 years who visited AL-Numan Teaching Hospital for routine check-ups from September 2023 to April 2024. Blood samples ( 5\u2005ml) were collected and serum was separated for antibody testing using commercial ELISA kits.\n                      <jats:bold>Inclusion cases<\/jats:bold>\n                      included; adult's patients aged 18\u201360 years with no active symptoms of viral infection.\n                      <jats:bold>Exclusion cases<\/jats:bold>\n                      included immunocompromised patients and those receiving antiviral therapy. Sample size was computed based on the estimated geographical incidence rates with 95% confidence interval and 5% margin of error.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      HSV-1 had an alarming 65.3% seroprevalence, with 14.3% exhibiting recent infection\/reactivation (IgM+). HSV-2 afflicted 22.4%, with a significant female preponderance (73.5%) and a strong connection with marital status (r\u2009=\u20090.605,\n                      <jats:italic toggle=\"yes\">p<\/jats:italic>\n                      \u2009&lt;\u20090.001). CMV seroprevalence has reached 24.4%. Age, marriage, and smoking were identified as significant risk factors, particularly for sexually transmitted HSV-2.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study demonstrates an extremely high herpesvirus load in Baghdad: two-thirds had HSV-1, while one-quarter have HSV-2 or CMV. The epidemic-level prevalence of HSV-1 necessitates prompt public health intervention. Strong demographic relationships, particularly the HSV-2 marital correlation, give actionable intervention targets. These findings establish Iraq's first complete herpesvirus baseline, highlighting the critical need for national surveillance infrastructure and tailored prevention initiatives to tackle this significant infectious disease burden.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1177\/10932607251355483","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T02:42:11Z","timestamp":1751337731000},"page":"83-89","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":0,"title":["Seroprevalence of Evaluation of Immunoglobulins for HSV-1, HSV-2, and CMV Viruses in Latency and Reactivation"],"prefix":"10.1177","volume":"33","author":[{"given":"Zahraa F.","family":"Al-Khero","sequence":"first","affiliation":[{"name":"Department of Medical Microbiology, Medicine College, Al-Iraqia University, Baghdad, Iraq"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zahra'a Abdul AL-Aziz","family":"Yousif","sequence":"additional","affiliation":[{"name":"Ibn Sina University of Medical and Pharmaceutical Sciences, Baghdad, Iraq"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah A.","family":"AL-waeely","sequence":"additional","affiliation":[{"name":"Department of Medical Microbiology, Medicine College, Karbala University, Karbala, Iraq"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6202-0109","authenticated-orcid":false,"given":"Sahar Taha","family":"Hatif","sequence":"additional","affiliation":[{"name":"Department of Microbiology, College of Medicine, AL-Iraqia University, Baghdad, Iraq"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-7432-3600","authenticated-orcid":false,"given":"Halah","family":"Kamal Al-Qazzaz","sequence":"additional","affiliation":[{"name":"Department of Biotechnology, College of Science, University of Baghdad, Baghdad, Iraq"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"e_1_3_4_2_2","article-title":"Structure of the herpes-simplex virus portal-vertex","author":"McElwee M","year":"2018","unstructured":"McElwee M, Vijayakrishnan S, Rixon FJ, et al. Structure of the herpes-simplex virus portal-vertex. bioRxiv 2018. doi: https:\/\/doi.org\/10.1101\/290544","journal-title":"bioRxiv"},{"key":"e_1_3_4_3_2","article-title":"Structure of herpes simplex virus pUL7:pUL51, a conserved complex required for efficient herpesvirus assembly","author":"Butt BG","year":"2019","unstructured":"Butt BG, Owen DJ, Jeffries CM, et al. Structure of herpes simplex virus pUL7:pUL51, a conserved complex required for efficient herpesvirus assembly. bioRxiv 2019. doi: https:\/\/doi.org\/10.1101\/810663","journal-title":"bioRxiv"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12864-022-08789-x"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-019-1285-x"},{"key":"e_1_3_4_6_2","first-page":"6","article-title":"Seroprevalence of herpes simplex virus type-1 antibodies (IgM, IgG) in smokers in Kirkuk City-Iraq","volume":"21","author":"Zangana LMM","year":"2023","unstructured":"Zangana LMM. Seroprevalence of herpes simplex virus type-1 antibodies (IgM, IgG) in smokers in Kirkuk City-Iraq. Tikrit J Pure Sci 2023; 21: 6\u201340.","journal-title":"Tikrit J Pure Sci"},{"key":"e_1_3_4_7_2","article-title":"Herpes simplex virus type 2 (HSV-2) infection","volume":"3","author":"Alitter QT","year":"2023","unstructured":"Alitter QT, Han A. Herpes simplex virus type 2 (HSV-2) infection. Private Pract Infect Dis 2023; 3. doi: https:\/\/doi.org\/10.55636\/ppid3010004","journal-title":"Private Pract Infect Dis"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1099\/vir.0.000128"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1542\/pir.2018-0175"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/ANC.0000000000001087"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1177\/2515690X221078004"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2024.0367"},{"key":"e_1_3_4_13_2","first-page":"84","article-title":"Seroepidemiology of herpes Simplex viruses type 1 and 2 in pregnant women in Croatia","volume":"60","author":"Vilibic-Cavlek T","year":"2024","unstructured":"Vilibic-Cavlek T, Belamaric M, Ferenc T, et al. Seroepidemiology of herpes Simplex viruses type 1 and 2 in pregnant women in Croatia. Medicina (Kaunas) 2024; 60: 84.","journal-title":"Medicina (Kaunas)"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2021.825049"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI179483"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.26719\/2020.26.5.609"},{"key":"e_1_3_4_17_2","article-title":"Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas","volume":"2","author":"Crider K","year":"2022","unstructured":"Crider K, Williams J, Qi YP, et al. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Cochrane Database Syst Rev 2022; 2: CD014217.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.52547\/ibj.3828"},{"key":"e_1_3_4_19_2","first-page":"96","article-title":"Seroprevalence of herpes simplex virus types 1 and 2 among pregnant women in south-western Romania","volume":"14","author":"Radoi CL","year":"2024","unstructured":"Radoi CL, Cristea OM, Vulcanescu DD, et al. Seroprevalence of herpes simplex virus types 1 and 2 among pregnant women in south-western Romania. Life (Basel) 2024; 14: 96.","journal-title":"Life (Basel)"},{"key":"e_1_3_4_20_2","volume-title":"StatPearls","author":"Gupta M","year":"2024","unstructured":"Gupta M, Shorman M. Cytomegalovirus. In StatPearls. Treasure Island (FL): StatPearls Publishing, 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK459185\/."},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.21123\/bsj.2021.18.2(Suppl.).1086"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.3390\/v15112142"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12889-022-13971-7"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapediatrics.2020.3009"},{"key":"e_1_3_4_25_2","article-title":"Seroprevalence of anti-cytomegalovirus IgG antibody among women of childbearing age attending selected hospitals in Kaduna State, Nigeria","author":"Anchau Z","year":"2024","unstructured":"Anchau Z, Suleiman A, Olonitola O, et al. Seroprevalence of anti-cytomegalovirus IgG antibody among women of childbearing age attending selected hospitals in Kaduna State, Nigeria. Microbes Infect Dis 2024. doi: https:\/\/doi.org\/10.21608\/mid.2024.258705.1739","journal-title":"Microbes Infect Dis"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jinf.2019.07.012"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-0691.2006.01475.x"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.3390\/v14051115"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrp.2023.101513"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.9.2300226"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12985-023-02157-1"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2024.07.049"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics12102368"},{"key":"e_1_3_4_34_2","article-title":"Seroprevalence of herpes simplex virus type 1 and 2 in Taiwan and risk factor analysis, 2007","volume":"10","author":"Shen JH","year":"2015","unstructured":"Shen JH, et al. Seroprevalence of herpes simplex virus type 1 and 2 in Taiwan and risk factor analysis, 2007. PLoS One 2015; 10: e0134178.","journal-title":"PLoS One"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82213-4"},{"key":"e_1_3_4_36_2","doi-asserted-by":"publisher","DOI":"10.29252\/ibj.24.2.136"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-37833-8"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241511989"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom14070802"},{"key":"e_1_3_4_40_2","article-title":"Herpes simplex virus type \u22122 (HSV-2) and HIV co- infection dynamics with optimal control","author":"Edogbanya HO","year":"2024","unstructured":"Edogbanya HO, Momoh SO, Sani U. Herpes simplex virus type \u22122 (HSV-2) and HIV co- infection dynamics with optimal control. Int J Dev Math 2024. doi: https:\/\/doi.org\/10.62054\/ijdm\/0101.09","journal-title":"Int J Dev Math"}],"container-title":["Human Antibodies"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10932607251355483","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10932607251355483","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10932607251355483","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:22:51Z","timestamp":1777447371000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/10932607251355483"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":39,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1177\/10932607251355483"],"URL":"https:\/\/doi.org\/10.1177\/10932607251355483","relation":{},"ISSN":["1093-2607","1875-869X"],"issn-type":[{"value":"1093-2607","type":"print"},{"value":"1875-869X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]}}}